Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Related Citations for PubMed (Select 22483513)

1.
2.

A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.

Park KK, Wu JJ, Koo J.

J Eur Acad Dermatol Venereol. 2013 Jul;27(7):899-906. doi: 10.1111/j.1468-3083.2012.04611.x. Epub 2012 Jun 15.

PMID:
22702846
3.

Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.

Calzavara-Pinton PG, Sala R, Arisi M, Rossi MT, Venturini M, Ortel B.

Br J Dermatol. 2013 Jul;169(1):130-6. doi: 10.1111/bjd.12277.

PMID:
23834117
4.

Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis.

De Simone C, D'Agostino M, Capizzi R, Capponi A, Venier A, Caldarola G.

Eur J Dermatol. 2011 Jul-Aug;21(4):568-72. doi: 10.1684/ejd.2011.1330.

PMID:
21697032
5.

Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.

Gambichler T, Tigges C, Scola N, Weber J, Skrygan M, Bechara FG, Altmeyer P, Kreuter A.

Br J Dermatol. 2011 Jun;164(6):1383-6. doi: 10.1111/j.1365-2133.2011.10358.x.

PMID:
21466532
6.

Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.

Mazzotta A, Esposito M, Costanzo A, Chimenti S.

Am J Clin Dermatol. 2009;10(5):319-24. doi: 10.2165/11310770-000000000-00000.

PMID:
19658444
7.

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.

Kircik L, Bagel J, Korman N, Menter A, Elmets CA, Koo J, Yang YC, Chiou CF, Dann F, Stevens SR; Unite Study Group.

J Drugs Dermatol. 2008 Mar;7(3):245-53.

PMID:
18380206
9.

Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study.

Strober BE, Poulin Y, Kerdel FA, Langley RG, Gu Y, Gupta SR, Okun MM, Papp KA.

J Am Acad Dermatol. 2011 Apr;64(4):671-81. doi: 10.1016/j.jaad.2010.03.009.

PMID:
21414495
10.

Targeted 307 nm UVB-phototherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol.

Wollina U, Koch A, Scheibe A, Seme B, Streit I, Schmidt WD.

Skin Res Technol. 2012 May;18(2):212-8. doi: 10.1111/j.1600-0846.2011.00556.x. Epub 2011 Sep 4.

PMID:
22092772
11.

Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept.

Wolf P, Hofer A, Legat FJ, Bretterklieber A, Weger W, Salmhofer W, Kerl H.

Br J Dermatol. 2009 Jan;160(1):186-9. doi: 10.1111/j.1365-2133.2008.08926.x. Epub 2008 Nov 25.

PMID:
19067710
12.

[Analysis of the cost effectiveness of home-based phototherapy with narrow-band UV-B radiation compared with biological drugs for the treatment of moderate to severe psoriasis].

Vañó-Galván S, Gárate MT, Fleta-Asín B, Hidalgo A, Fernández-Guarino M, Bermejo T, Jaén P.

Actas Dermosifiliogr. 2012 Mar;103(2):127-37. doi: 10.1016/j.ad.2011.05.002. Epub 2011 Oct 27. Spanish.

PMID:
22036021
13.

Pilot evaluation of supra-erythemogenic phototherapy with excimer laser in the treatment of patients with moderate to severe plaque psoriasis.

Gattu S, Pang ML, Pugashetti R, Malick F, Hong J, Bowers E, Levatter JI, Koo J.

J Dermatolog Treat. 2010 Jan;21(1):54-60. doi: 10.3109/09546630903203756.

PMID:
19711219
14.

Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis.

Köllner K, Wimmershoff MB, Hintz C, Landthaler M, Hohenleutner U.

Br J Dermatol. 2005 Apr;152(4):750-4.

PMID:
15840108
15.

Low-dose etanercept therapy in moderate to severe psoriasis in Korean.

Na JI, Kim JH, Park KC, Youn SW.

J Dermatol. 2008 Aug;35(8):484-90. doi: 10.1111/j.1346-8138.2008.00508.x.

PMID:
18789067
16.

Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.

Gelfand JM, Wan J, Callis Duffin K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF Jr, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, Van Voorhees AS.

Arch Dermatol. 2012 Apr;148(4):487-94. doi: 10.1001/archdermatol.2012.370.

17.

A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis.

Cameron H, Dawe RS, Yule S, Murphy J, Ibbotson SH, Ferguson J.

Br J Dermatol. 2002 Nov;147(5):973-8.

PMID:
12410709
18.

The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.

Trott J, Gerber W, Hammes S, Ockenfels HM.

Eur J Dermatol. 2008 Jan-Feb;18(1):55-60. Epub 2007 Dec 18.

PMID:
18086590
19.

A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept.

Lynde CW, Gupta AK, Guenther L, Poulin Y, Levesque A, Bissonnette R.

J Dermatolog Treat. 2012 Aug;23(4):261-7. doi: 10.3109/09546634.2011.607795. Epub 2011 Aug 10.

PMID:
21797805
20.

Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach.

Gerber W, Arheilger B, Ha TA, Hermann J, Ockenfels HM.

Br J Dermatol. 2003 Dec;149(6):1250-8.

PMID:
14674904
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk